Ildong Pharmaceutical Appoints Park Jae-hong as R&D Head
Ildong Pharmaceutical appointed Dr. Park Jae-hong as new R&D Head (President) effective April 1st. Park has extensive experience at global pharmaceutical companies including Janssen, Takeda, and Boehringer Ingelheim.
Ildong Pharma launches first TV ad for Roihi-Tsuboko
Ildong Pharma launches first TV ad for Roihi-Tsuboko coin plaster, highlighting its availability in Korean pharmacies and its pain-relieving properties.
Ildong Pharma and Ildong Holdings hold annual meetings
Ildong Pharma and Ildong Holdings held annual shareholder meetings, approving financial statements and electing directors. Both companies pledged to focus on growth and improving business performance.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.
Get full access to view complete information
1 - 25 of 35
Get full access to view complete information
Frequently Asked Questions Regarding ILDONG Pharmaceutical Company
Company Overview
1941
Founded
Pharmaceutical Manufacturing
Industry
South Korea
Location
8,094,304
Ranking
200 employees
Size
Similar Companies
Get full access to view complete information
Frequently Asked Questions Regarding ILDONG Pharmaceutical Company
Start your journey today
Start with the platform — or start with a conversation
Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.